| HOME >> BIOLOGY >> TECHNOLOGY |
rights to technology from licensors; liability for patent claims and
other claims asserted against us; our ability to obtain and enforce
timely patent and other intellectual property protection for our
technology and products; the ability to enter into, and to maintain,
corporate alliances relating to the development and commercialization of
our technology and products; market acceptance of our technology and
products; our ability to successfully manufacture, market and sell our
products; the ability of Boston Scientific Corporation to successfully
manufacture, market and sell their paclitaxel-eluting coronary stent
products; the continued availability of capital to finance our
activities; our ability to achieve the financial benefits expected as a
result of the acquisition of American Medical Instruments Holdings, Inc.
("AMI"); and any other factors referenced in our annual information form
and other filings with the applicable Canadian securities regulatory
authorities or the SEC. Given these uncertainties, assumptions and risk
factors, readers are cautioned not to place undue reliance on such
forward-looking statements. We disclaim any obligation to update any such
factors or to publicly announce the result of any revisions to any of the
forward-looking statements contained in this press release to reflect
future results, events or developments.
Quill(TM) is a trademark of Quill Medical, Inc., a wholly-owned
subsidiary of Angiotech Pharmaceuticals, Inc.
(C)2008 Angiotech Pharmaceuticals, Inc. All Rights Reserved.
Vascular Wrap(TM) is a trademark of Angiotech Pharmaceuticals, Inc.
BioPince(TM) is a trademark of Medical Device Technologies, Inc.
Skater(TM) is a trademark of PBN MEDICALS DENMARK A/S.
MultiStem(R) is a registered trademark of At
'/>"/>
| SOURCE Angiotech Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |